Press Releases By ANAVEX Life Sciences Corp.

Anavex Successfully Completes A Phase 1 Clinical Trial For ANAVEX 2-73

Neurology Nov 17, 2011

ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimer's disease clinical trials

Neurology Sep 21, 2009

ANAVEX Appoints Dr Herve de Kergrohen as CEO to Lead Company Through Clinical Trials And Future Growth

Pharmaceuticals Jun 16, 2009

Pharmawire - Medivation, Anavex May Lower Oxidative Stress

Neurology Apr 10, 2009